AREV Life Sciences Global Corp.
AREV Life Sciences Global Corp.
Your view on AREVF
Overview
What the company does, where it operates, and who runs it.
About AREV Life Sciences Global Corp.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Michael C. Withrow
- Headquarters
- 18 - 91 Golden Drive, Coquitlam, BC, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Michael C. Withrow
- Headquarters
- 18 - 91 Golden Drive, Coquitlam, BC, CA
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada.
The company's CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles.
Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets.
In addition, the company's products address the areas of health, which include sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, as well as other specific ailments. Further, it offers nutraceutical product formulations under the Bare brand name; and ready-to-use therapeutic food products under the SUS-TAINN name.
The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for AREV Life Sciences Global Corp., and the rating behind it. AREVF last traded at $0.0005; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for AREV Life Sciences Global Corp.. Starting points for AREV Life Sciences Global Corp.: EPS -$0.05, beta 5.21 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for AREV Life Sciences Global Corp.. AREV Life Sciences Global Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for AREV Life Sciences Global Corp.. Trailing twelve-month EPS for AREV Life Sciences Global Corp. stands at -$0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for AREV Life Sciences Global Corp.. AREV Life Sciences Global Corp. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
AREV Life Sciences Global Corp. valued side by side against its closest peers. AREV Life Sciences Global Corp. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold AREV Life Sciences Global Corp., and how their positions are changing. At a $15,881 market value, institutional positions materially move AREV Life Sciences Global Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by AREV Life Sciences Global Corp. executives and directors. Shares of AREV Life Sciences Global Corp. have traded between $0.0005 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming AREV Life Sciences Global Corp.. AREV Life Sciences Global Corp. is a $15,881 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming AREV Life Sciences Global Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for AREV Life Sciences Global Corp.. Coverage tracks AREV Life Sciences Global Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.